The US government contols who may produce insulin.
No, they don't.
See? Government caused this problem.
No, they didn't.
Insulin insulated: barriers to competition and affordability in ...

National Institutes of Health (NIH) (.gov)
https://www.ncbi.nlm.nih.gov › articles › PMC8249113
by R Knox · 2020 · Cited by 28 —
Insulin prices in the United States are skyrocketing. In addition to several challenges common to high-priced prescription drugs,
insulin faces several ...
Even if reforms can be instituted to increase competition in the United States insulin market, the current market control of the Novo Nordisk, Sanofi, and Eli Lilly—the ‘Big Three’—may prevent successful entry of new products and their ability to compete.
The massive market control of the Big Three serves as a practical barrier to entry, and the potential for anticompetitive conduct magnifies this risk.
The Big Three have been accused of anticompetitive conduct in the past, and a new competitor could elicit anticompetitive tactics in response.
In other countries, the Big Three have already taken advantage of their dominant market position to price out other competitors. Novo Nordisk, for example, has priced out competitors in India.
In the event of a new market entrant in the United States, the Big Three could offer substantially cheaper prices for their insulin products, pricing competitors out of the market and protecting the existing oligopoly.
Of course I do. The reason hospital costs are insane is the hospitals have to recoup the money they outlay treating people for free.
As usual, you're angry at the wrong people.
BS.
Rising Prices and Health Care “Empires”

JAMA Network
https://jamanetwork.com › journals › jama › fullarticle
by AB Bindman · 2020 · Cited by 8 — Such
price differences are even greater for
hospital-based care. The
prices for cardiac bypass, angioplasty, hip replacement, knee ...
High prices for health care services is a well-known aspect of the US health care system. International comparisons reveal US prices that are
many times higher than charged in European and other high-income countries for the vast majority of diagnostic and therapeutic procedures.
For example, outpatient computed tomography and magnetic resonance imaging scans are priced 4 to 5 times higher in the United States than in the Netherlands and Switzerland. Such price differences are even greater for hospital-based care.
The prices for cardiac bypass, angioplasty, hip replacement, knee replacement, appendectomy, hysterectomy, and normal delivery are all
2 to 4 times higher in the United States than in other industrialized countries.
Hospitals' labor costs increased 258% over the last three ...

Healthcare Finance News
https://www.healthcarefinancenews.com › news › hospit...
Mar 10, 2023 —
Hospitals' labor
costs increased 258% over the last three years · Relying on labor from contract staffing firms contributed to higher overall ...